CÇü °£¿° ¹ÙÀÌ·¯½º °¨¿°ÀÇ ½Å¼Ó ¼±º°°Ë»ç·Î¼­ OraQuick HCV ½Å¼ÓÇ×ü °Ë»çÀÇ Æò°¡
Evaluation of the OraQuick HCV Rapid Antibody Test as a Screening Test for Hepatitis C Virus Infection

Laboratory Medicine and Quality Assurance 2013³â 35±Ç 2È£ p.100 ~ p.106

¹æÇØÀÎ(Bang Hae-In) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
ÃÖÅÂÀ±(Choi Tae-Youn) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
½ÅÁ¤¿ø(Shin Jeong-Won) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
¹Ú³ëÁø(Park Ro-Jin) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
¹ÚÀº¼ö(Park Eun-Su) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç

Abstract

¹è°æ: CÇü °£¿° ¹ÙÀÌ·¯½º(hepatitis C virus, HCV) °¨¿°ÀÇ Áø´ÜÀ» À§ÇÑ ¸¹Àº ¹æ¹ýµéÀÌ °³¹ßµÇ¾î ¿Ô´Ù. ¼±º°°Ë»ç´Â HCV Ç×ü°Ë»ç·Î È¿¼Ò¸é¿ª¹ý°ú È­Çй߱¤¸é¿ª¹ý(chemiluminescence immunoassay, CLIA)À» ÁÖ·Î ÀÌ¿ëÇÏ°í ÀÖÀ¸¸ç ÃÖ±Ù ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ´Â OraQuick HCV ½Å¼ÓÇ×ü°Ë»ç´Â Ç÷¾×, ±¸°­¾×À» ÀÌ¿ëÇÏ¿© HCV Ç×ü¸¦ 20ºÐ À̳» °ËÃâÇÒ ¼ö ÀÖ´Â °£ÀÌ°Ë»çÀÌ´Ù. º» ¿¬±¸¿¡¼­´Â OraQuick°Ë»çÀÇ ¼º´ÉÀ» CLIA¿Í ºñ±³ÇÏ¿© Æò°¡ÇÏ°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý: 2012³â 9¿ùºÎÅÍ 2013³â 1¿ù±îÁö HCV°Ë»ç°¡ ÀÇ·ÚµÈ 150°Ëü¸¦ ´ë»óÀ¸·Î ÇÏ¿´´Ù. HCV Ç×ü°Ë»ç´Â ADVIA Centaur Àåºñ¸¦ ÀÌ¿ëÇÑ CLIA¿Í OraQuick Ç×ü°Ë»ç·Î ½Ç½ÃÇÏ¿´´Ù. HCV ½Ç½Ã°£ PCR °Ë»ç´Â COBAS AmpliPrep/COBAS TaqMan HCV test Å°Æ®¸¦ »ç¿ëÇÏ¿´´Ù.

°á°ú: 150°Ëü Áß HCV PCR ¾ç¼ºÀº 59°Ëü(39.3%)¿´°í À½¼ºÀº 91°Ëü(60.7%)¿´´Ù. PCR ¾ç¼º 59°Ëü Áß ¸ðµç °Ëü¿¡¼­ CLIA Ç×ü°Ë»ç ¾ç¼ºÀ̾úÀ¸³ª ÀÌ Áß µÎ °Ëü¿¡¼­ OraQuick Ç×ü°Ë»ç À½¼ºÀ̳ª¿Ô´Ù. PCR À½¼º 91°Ëü Áß 50°Ëü´Â µÎ °¡Áö ¹æ¹ý ¸ðµÎ¿¡¼­ À½¼ºÀÌ ³ª¿Ô°í ³ª¸ÓÁö PCR À½¼º 41°Ëü Áß, 21°Ëü´Â µÎ °¡Áö ¹æ¹ý¿¡¼­ ¾ç¼º, 20°Ëü´Â CLIA Ç×ü°Ë»ç¿¡¼­ ¾ç¼º, raQuick Ç×ü°Ë»ç¿¡¼­ À½¼º°á°ú¸¦ º¸¿´´Ù.

°á·Ð: OraQuick Ç×ü°Ë»ç´Â CLIA Ç×ü°Ë»çº¸´Ù ¹Î°¨µµ´Â ³·À¸³ª ½Å¼ÓÇÏ°Ô °Ë»çÇÒ ¼ö ÀÖ°í Ç÷¾×À̳ª ±¸°­ °Ëü·Î °£ÆíÇÏ°Ô °Ë»ç°¡ °¡´ÉÇÏ´Ù´Â Á¡¿¡¼­ HCV °¨¿°°ü¸®¿¡ À¯¿ëÇÏ°Ô »ç¿ëµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢µÈ´Ù.
Background: Among the multitude of tests developed for the diagnosis of hepatitis C virus (HCV) infection, the enzyme immunoassay and the chemiluminescence immunoassays (CLIA) are the most commonly used. The OraQuick HCV Rapid Antibody Test is also popular because it can detect HCV antibodies from blood or saliva within 20 minutes. In this study, we compared the performances of the OraQuick HCV Rapid Antibody Test and CLIA in the diagnosis of HCV infection.

Methods: We tested 150 serum samples from Soonchunhyang University Seoul Hospital for HCV between November 2012 and January 2013 using CLIA (ADVIA Centaur) as well as the OraQuick test. The data from both tests were compared to the results of HCV real-time PCR (COBAS AmpliPrep/COBAS TaqMan HCV test kit).

Results: We tested 150 serum samples from Soonchunhyang University Seoul Hospital for HCV between November 2012 and January 2013 using CLIA (ADVIA Centaur) as well as the OraQuick test. The data from both tests were compared to the results of HCV real-time PCR (COBAS AmpliPrep/COBAS TaqMan HCV test kit).

Conclusion: We tested 150 serum samples from Soonchunhyang University Seoul Hospital for HCV between November 2012 and January 2013 using CLIA (ADVIA Centaur) as well as the OraQuick test. The data from both tests were compared to the results of HCV real-time PCR (COBAS AmpliPrep/COBAS TaqMan HCV test kit).

Å°¿öµå

Hepatitis C virus, Hepatitis C antibodies, HCV real-time PCR
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Although the OraQuick test showed a marginally lower sensitivity for HCV detection than CLIA, we conclude that it is still beneficial because it is rapid and can be performed using blood and saliva samples.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå